Development and optimization of ifosfamide nanostructured lipid carriers for oral delivery using response surface methodology

Applied Nanoscience (Switzerland)

Volumn 6, Issue 2, 2016, Pages 159-173

  Velmurugan, Ramaiyan ^a   Selvamuthukumar, Subramanian ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

Ifosfamide; Nanostructured lipid carriers; Oral delivery; Response surface methodology; Solvent diffusion technique; Sustained release

Indexed keywords

CHITOSAN; DRUG PRODUCTS; EFFICIENCY; HIGH RESOLUTION TRANSMISSION ELECTRON MICROSCOPY; MONOUNSATURATED FATTY ACIDS; MORPHOLOGY; OLEIC ACID; PARTICLE SIZE; PARTICLE SIZE ANALYSIS; SODIUM; SODIUM ALGINATE; SURFACE MORPHOLOGY; SURFACE PROPERTIES; TARGETED DRUG DELIVERY;

IFOSFAMIDE; NANOSTRUCTURED LIPID CARRIERS; ORAL DELIVERY; RESPONSE SURFACE METHODOLOGY; SOLVENT DIFFUSION; SUSTAINED RELEASE;

CONTROLLED DRUG DELIVERY;

EID: 84986921038     PISSN: 21905509     EISSN: 21905517     Source Type: Journal    
DOI: 10.1007/s13204-015-0434-6     Document Type: Article

References (32)

1. Ahn JH, Kim YP, Lee YM, Seo EM, Lee KW, Kim HS (2008) Optimization of microencapsulation of seed oil by response surface methodology. Food Chem 107:98–105
2. Alexander RL, Behme RJ, Brooke D, Scott JA (1993) Lyophilized ifosfamide compositions, US5227373 A, Jul 13
3. Battaglia L, Trotta M, Gallarate M, Carlotti ME, Zara GP, Bargoni A (2007) Solid lipid nanoparticles formed by solvent-in-water emulsion-diffusion technique: development and influence on insulin stability. J Microencapsul 7:660–672
4. Bhumkar DR, Pokharkar VB (2006) Studies on effect of pH on cross-linking of chitosan with sodium tripolyphosphate: a technical note. AAPS Pharm Sci Tech 7:45–50
5. Binks BP, Lumsdon SO (2000) Catastrophic phase inversion of water-in-oil emulsions stabilized by hydrophobic silica. Langmuir 16:2539–2547
6. Box GEP, Hunter JS (1957) Multi-factor experimental design for exploring response surfaces. Ann Math Stat 28:195–241
7. Boyd BJ, Whittaker DV, Khoo S (2006) Lyotropic liquid crystalline phases formed from glycerate surfactants as sustained release drug delivery systems. Int J Pharm 309:218–226
8. Budhian A, Siegel SJ, Winey KI (2007) Haloperidol-loaded PLGA nanoparticles: systematic study of particle size and drug content. Int J Pharm 2:367–375
9. Chen CC, Tsai TH, Huang ZR, Fang JY (2010) Effects of lipophilic emulsifiers on the oral administration of lovastatin from nanostructured lipid carriers: physicochemical characterization and pharmacokinetics. Eur J Pharm Biopharm 3:474–482
10. Das S, Chaudhury A (2011) Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery. AAPS Pharm Sci Tech 12:62–76
11. Gaumet M, Gurny R, Delie F (2009) Localization and quantification of biodegradable particles in an intestinal cell models: the influence of particle size. Eur J Pharm Sci 36:465–473
12. Hu FQ, Zhang Y, Du YZ, Yuan H (2008) Nimodipine loaded lipid nanospheres prepared by solvent diffusion method in a drug saturated aqueous system. Int J Pharm 2:146–152
13. Kassama LS, Shi J, Mittal GS (2008) Optimization of supercritical fluid extraction of lycopene from tomato skin with central composite rotatable design model. Sep Purif Technol 60:278–284
14. Liu H, Gao C (2009) Preparation and properties of ionically cross-linked chitosan nanoparticles. Polym Adv Technol 20:613–619
15. Mehnert W, Mader K (2001) Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev 47:165–196
16. Muller RH, Radtke M, Wissing SA (2002a) Nanostructured lipid matrices for improved microencapsulation of drugs. Int J Pharm 2:121–128
17. Muller RH, Radtke M, Wissing SA (2002b) Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev 54:131–155
18. Myers RH, Montgomery DC (1995) Response surface methodology. Wiley, New York
19. Myers RH, Montgomery DC (2002) Response surface methodology: process and product optimization using designed experiments. Wiley, New York
20. Pandit AA, Dash AK (2011) Surface modified lipid nanoparticulate formulation for ifosfamide: development and characterization. Nanomedicine 8:1397–1412
21. Radtke M, Souto EB, Muller RH (2005a) Nanostructured lipid carriers: a novel generation of solid lipid drug carriers. Pharm Technol Eur 17:45–50
22. Radtke M, Souto EB, Muller RH (2005b) Nanostructured lipid carriers: a novel generation of solid lipid drug carriers. Pharm Technol Eur 17:45–50
23. Reddy LH, Vivek K, Bakshi N, Murthy RS (2006) Tamoxifen citrate loaded solid lipid nanoparticles (SLN): preparation, characterization, in vitro drug release, and pharmacokinetic evaluation. Pharm Dev Technol 2:167–177
24. Sannan T, Kurita K, Lwakura Y (1976) Effect of deacetylation on solubility. Die Makromolekulare Chemie 12:3589–3600
25. Selvamuthukumar S, Velmurugan R (2012) Nanostructured lipid carriers: a potential drug carrier for cancer chemotherapy. Lipids Health Dis 11:159
26. Shah KA, Date AA, Joshi MD, Patravale VB (2007) Solid lipid nanoparticles (SLN) of tretinoin: potential in topical delivery. Int J Pharm 2:163–171
27. Song X, Zhao Y, Hou S, Xu F, Zhao R, He J, Cai Z, Li Y, Chen Q (2008) Dual agents loaded PLGA nanoparticles: systematic study of particle size and drug entrapment efficiency. Eur J Pharm Biopharm 2:445–453
28. Trickler WJ, Nagvekar AA, Dash AK (2008) A novel nanoparticle formulation for sustained paclitaxel delivery. AAPS Pharm Sci Tech 9:486–493
29. Trickler WJ, Khurana J, Nagvekar AA (2010) Chitosan and glycerol monooleate nanostructure containing germcitabine: potential delivery system for pancreatic cancer treatment. AAPS Pharm Sci Tech 1:392–401
30. Trotta M, Debernardi F, Caputo O (2003) Preparation of solid lipid nanoparticles by a solvent emulsification-diffusion technique. Int J Pharm 2:153–160
31. Westesen K, Bunjes H, Koch MHJ (1997) Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential. J Control Release 48:223–236
32. Yuan H, Wang LL, Du YZ, You Hu FQ, Zeng S (2007) Preparation and characteristics of nanostructured lipid carriers for control-releasing progesterone by melt-emulsification. Colloids Surf B Biointerfaces 2:174–179